By Paul A. Harris
Portland, Ore., Sept. 24 – Global Medical Response Inc. priced a downsized $600 million issue of five-year senior secured notes (B2/B) at par to yield 6½% on Thursday, according to market sources.
The issue size was decreased from $740 million after having earlier been upsized from $500 million.
The yield printed at the wide end of yield talk in the 6 3/8% area and in line with initial guidance in the mid-6% area.
Morgan Stanley & Co. LLC was the left lead bookrunner. Joint bookrunners were KKR, Barclays, BofA Securities Inc., Capital One Securities Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Jefferies LLC, J.P. Morgan Securities LLC and Regions Securities LLC.
With the downsize, $140 million of proceeds were shifted to the concurrent term loan, increasing the loan size to $1.64 billion from $1.5 billion.
The Greenwood Village, Colo.-based medical care provider, previously known as Air Medical, plans to use the proceeds from the notes and loans to refinance its term loan due 2022 and its 6 3/8% senior notes due 2023.
Issuer: | Global Medical Response Inc.
|
Amount: | $600 million, decreased from $740 million after upsizing from $500 million
|
Maturity: | Oct. 1, 2025
|
Securities: | Senior secured notes
|
Left lead bookrunner: | Morgan Stanley & Co. LLC
|
Joint bookrunners: | KKR, Barclays, BofA Securities Inc., Capital One Securities Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Jefferies LLC, J.P. Morgan Securities LLC and Regions Securities LLC
|
Coupon: | 6½%
|
Price: | Par
|
Yield: | 6½%
|
Spread: | 623 bps
|
First call: | Oct. 1, 2021 at 103.25
|
Equity clawback: | 40% at 106.5 until Oct. 1, 2021
|
Trade date: | Sept. 24
|
Settlement date: | Oct. 2
|
Ratings: | Moody's: B2
|
| S&P: B
|
Distribution: | Rule 144A and Regulation S for life
|
Price talk: | 6 3/8% area
|
Marketing: | Roadshow
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.